Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome.

@article{Kumar2010AntituberculosisTA,
  title={Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome.},
  author={R Kumar and Vikram Bhatia and Shankar Prasad Khanal and V. Sreenivas and Siddhartha Datta Gupta and Subrat Kumar Panda and Subrat kumar Acharya},
  journal={Hepatology},
  year={2010},
  volume={51 5},
  pages={1665-74}
}
UNLABELLED Antituberculosis therapy (ATT)-associated acute liver failure (ATT-ALF) is the commonest drug-induced ALF in South Asia. Prospective studies on ATT-ALF are lacking. The current study prospectively evaluated the magnitude, clinical course, outcome, and prognostic factors in ATT-ALF. From January 1986 to January 2009, 1223 consecutive ALF patients were evaluated: ATT alone was the cause in 70 (5.7%) patients. Another 15 (1.2%) had ATT and simultaneous hepatitis virus infection. In 44… CONTINUE READING
27 Extracted Citations
37 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 27 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 37 references

Acute liver failure

  • AJ Sanyal, RT Stravitz
  • 2003
Highly Influential
8 Excerpts

Similar Papers

Loading similar papers…